S. Rao

639 total citations
29 papers, 403 citations indexed

About

S. Rao is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, S. Rao has authored 29 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Hematology. Recurrent topics in S. Rao's work include CAR-T cell therapy research (4 papers), Molecular Biology Techniques and Applications (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). S. Rao is often cited by papers focused on CAR-T cell therapy research (4 papers), Molecular Biology Techniques and Applications (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). S. Rao collaborates with scholars based in Italy, India and United States. S. Rao's co-authors include Kailash Prasad, Richard W. Sherbaniuk, Brian J. Sproule, Gautam Dravid, Marco A. Pierotti, Rosella Silvestrini, Maria Grazia Daidone, Elvira Benini, S. Pilotti and Giorgio Parmiani and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and American Journal of Obstetrics and Gynecology.

In The Last Decade

S. Rao

25 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Rao Italy 9 144 138 126 82 56 29 403
Masako Okawa‐Takatsuji Japan 14 70 0.5× 42 0.3× 88 0.7× 161 2.0× 32 0.6× 28 478
Sarah Downey United Kingdom 8 86 0.6× 257 1.9× 278 2.2× 22 0.3× 141 2.5× 15 552
Yusuke Tomita Japan 14 348 2.4× 80 0.6× 162 1.3× 49 0.6× 46 0.8× 40 689
Shigeki Yamagishi Japan 10 186 1.3× 65 0.5× 91 0.7× 28 0.3× 31 0.6× 34 429
P. J. Cagnoni United States 10 90 0.6× 151 1.1× 34 0.3× 17 0.2× 34 0.6× 16 312
Enrique López‐Aguilar Mexico 11 60 0.4× 71 0.5× 181 1.4× 19 0.2× 109 1.9× 25 457
Jun Won Um South Korea 13 90 0.6× 170 1.2× 77 0.6× 13 0.2× 23 0.4× 52 460
Anjela Tzontcheva United States 11 218 1.5× 107 0.8× 70 0.6× 166 2.0× 76 1.4× 29 677

Countries citing papers authored by S. Rao

Since Specialization
Citations

This map shows the geographic impact of S. Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Rao more than expected).

Fields of papers citing papers by S. Rao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Rao. The network helps show where S. Rao may publish in the future.

Co-authorship network of co-authors of S. Rao

This figure shows the co-authorship network connecting the top 25 collaborators of S. Rao. A scholar is included among the top collaborators of S. Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Rao. S. Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taylor, Peter C., Arthur Kavanaugh, Peter Nash, et al.. (2023). AB0290 EFFECT OF FILGOTINIB ON PAIN IN PATIENTS WITH RHEUMATOID ARTHRITIS IN THE PHASE 3 FINCH 1, 2 AND 3 STUDIES. Lirias (KU Leuven). 1326.2–1327. 1 indexed citations
2.
Jagadeesh, Deepa, Sarah McCue Horwitz, Nancy L. Bartlett, et al.. (2019). RESPONSE TO BRENTUXIMAB VEDOTIN BY CD30 EXPRESSION: RESULTS FROM FIVE TRIALS IN PTCL, CTCL, AND B‐CELL LYMPHOMAS. Hematological Oncology. 37(S2). 470–471. 4 indexed citations
3.
McDermott, David F., Brian I. Rini, Robert J. Motzer, et al.. (2018). Treatment-free interval (TFI) following discontinuation of first-line nivolumab plus ipilimumab (N+I) or sunitinib (S) in patients (Pts) with advanced renal cell carcinoma (aRCC): CheckMate 214 analysis. Annals of Oncology. 29. viii309–viii309. 15 indexed citations
4.
Banik, Avijit, et al.. (2008). The stem cell in the umbilical cord blood is not related to volume and nucleated cell count.
5.
Ma, Changqing, Meraj Aziz, S. Rao, et al.. (2007). Genomic copy number alterations in non-small cell lung cancers identified using CBS and MSA. Journal of Clinical Oncology. 25(18_suppl). 7695–7695. 1 indexed citations
6.
Porta, Caterina A. M. La, Silvia De Biasi, S. Rao, et al.. (2004). Molecular mechanism of vasculogenic mimicry. Cancer Research. 64. 1142–1142. 2 indexed citations
7.
Dravid, Gautam & S. Rao. (2002). Ex Vivo Expansion of Stem Cells from Umbilical Cord Blood: Expression of Cell Adhesion Molecules. Stem Cells. 20(2). 183–189. 29 indexed citations
8.
Rao, S., et al.. (1999). Expansion of haematopoietic stem cells in vitro: a challenge to stem cell biologists.. PubMed. 37(11). 1051–2. 3 indexed citations
9.
Daidone, Maria Grazia, Elvira Benini, S. Rao, Silvana Pilotti, & Rosella Silvestrini. (1998). Fixation Time and Microwave Oven Irradiation Affect Immunocytochemical p53 Detection in Formalin-Fixed Paraffin Sections. Applied Immunohistochemistry. 6(3). 140–144. 4 indexed citations
10.
Rao, S., et al.. (1997). DISTINCT mdm2/p53 EXPRESSION PATTERNS IN LIPOSARCOMA SUBGROUPS: IMPLICATIONS FOR DIFFERENT PATHOGENETIC MECHANISMS. The Journal of Pathology. 181(1). 14–24. 126 indexed citations
11.
Belli, Filiberto, Flavio Arienti, Josep Sulé-Suso, et al.. (1997). Active immunization of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: evaluation of efficacy and tolerability. Cancer Immunology Immunotherapy. 44(4). 197–203. 45 indexed citations
12.
Rao, S., et al.. (1996). AN ICAM‐1 LIKE CELL ADHESION MOLECULE IS RESPONSIBLE FOR CD34 POSITIVE HAEMOPOIETIC STEM CELLS ADHESION TO BONE‐MARROW STROMA. Cell Biology International. 20(4). 255–259. 11 indexed citations
13.
Belli, Filiberto, L. Mascheroni, Rosaria Bufalino, et al.. (1996). Biological activity and clinical efficacy of intravenous high-dose thymopentin in metastatic melanoma patients. Melanoma Research. 6(1). 63–69. 4 indexed citations
14.
Spinillo, Arsenio, et al.. (1994). Nucleolar organizer regions and cervical intraepithelial neoplasia among women with human immunodeficiency virus infection. American Journal of Obstetrics and Gynecology. 171(3). 773–777. 4 indexed citations
15.
Datar, Ram H., et al.. (1991). Antisense RNA therapy for CML — An hypothesis. Medical Hypotheses. 35(4). 307–310.
16.
Rao, Lang, et al.. (1989). A mitogenic factor from rat muscle. Cancer Letters. 45(1). 27–34.
17.
18.
Somasundaram, Rajasekharan, et al.. (1988). In vitro generation of effector cells cytotoxic to autologous targets from chronic myeloid leukemia patients in remission. Cancer Immunology Immunotherapy. 27(2). 177–82. 7 indexed citations
19.
Advani, Suresh H., et al.. (1986). Growth factors in chronic myelogenous leukemia. Cancer Letters. 32(3). 285–292. 5 indexed citations
20.
Rao, S., et al.. (1973). Cardiopulmonary effects of diazepam. Clinical Pharmacology & Therapeutics. 14(2). 182–189. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masako Okawa‐Takatsuji Breakdown of academic impact, for papers by Sarah Downey Breakdown of academic impact, for papers by Yusuke Tomita Breakdown of academic impact, for papers by Shigeki Yamagishi Breakdown of academic impact, for papers by P. J. Cagnoni Breakdown of academic impact, for papers by Enrique López‐Aguilar Breakdown of academic impact, for papers by Jun Won Um Breakdown of academic impact, for papers by Anjela Tzontcheva
Rankless by CCL
2026